Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
about
Calcium phosphate nanoparticles-based systems for siRNA deliveryGene therapy in pancreatic cancer.Innovative delivery of siRNA to solid tumors by super carbonate apatite.The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery.Enhancing endosomal escape for nanoparticle mediated siRNA delivery.Nanoformulations for therapy of pancreatic and liver cancers.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Calcium phosphate nanocoatings and nanocomposites, part 2: thin films for slow drug delivery and osteomyelitis.siRNA-Mediated SBF2 Silencing May Inhibit Pancreatic Cancer Cells via Attenuation of the TGF-β Signaling Pathway.Fine-tuning of charge-conversion polymer structure for efficient endosomal escape of siRNA-loaded calcium phosphate hybrid micelles.Nanostructural systems developed with positive charge generation to drug delivery.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.Calcium phosphate hybrid nanoparticles: self-assembly formation, characterization, and application as an anticancer drug nanocarrier.Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery.Decationized polyplexes for gene delivery.Calcium-based biomaterials for diagnosis, treatment, and theranostics.Calcium phosphate-based organic-inorganic hybrid nanocarriers with pH-responsive on/off switch for photodynamic therapy.Nanoparticles combined with growth factors: recent progress and applicationsPotent calcium phosphate nanoparticle surface coating for in vitro and in vivo siRNA delivery: a step toward multifunctional nanovectors
P2860
Q26744039-3EBB1B7F-44A6-42BE-8E21-085A6626880CQ34302954-D386EC6F-5CAF-4A60-89EA-A3F15CFBF298Q35571504-4B867804-223F-474A-A9EB-936FFFFA7D03Q38160450-2E616F5A-D5EB-4C98-B28E-6A5594325781Q38162492-24283714-8469-4D88-BFFC-F56EAF4FCA01Q38212473-0758D53A-C768-47B7-9198-5FA4CD94C328Q38495105-3ED5972C-CAEC-4266-A28B-B46317C89F52Q38682486-9C24333F-9F8F-4E29-9FC3-9345F3D6A0BCQ38739499-565EB6B5-142A-47C0-9604-1364E7283DDFQ38885999-D387F350-6BA6-4E4E-8EBA-AECF599E1313Q39006047-BA942521-7902-4E2C-8555-88C4EA17FE12Q39022735-65B2F8D1-4C73-4A2E-9342-C90808ECC0ADQ39028976-11CC4B42-E89B-4893-AE3C-26C11A14FE3FQ39165651-6BE38621-DB8A-4618-9804-BF7B296162D6Q41995279-CDB6F91F-4CD0-4966-ABF0-EA341B88DDDDQ45870434-CB8A4AAB-6135-4A38-AD8D-9E9142959AFEQ47231934-F4099A4E-8476-4ED3-88A4-E1DF4C966D25Q51447636-F70F8E5A-30A7-468B-9EC6-38A85320C6CBQ57377197-68439A9C-AA29-4BA7-994F-D193E1453E23Q58002746-16CDA654-1F74-4B78-95C5-0E61B7642A24
P2860
Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@en
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@nl
type
label
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@en
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@nl
prefLabel
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@en
Pancreatic cancer therapy by s ...... polymer hybrid nanoparticles.
@nl
P2093
P50
P1476
Pancreatic cancer therapy by s ...... l polymer hybrid nanoparticles
@en
P2093
Kanjiro Miyata
Kazunori Kataoka
Qixian Chen
R James Christie
Sumiyo Watanabe
Tomoya Suma
Yoshinori Maeda
P304
P356
10.1016/J.JCONREL.2012.05.005
P407
P577
2012-05-11T00:00:00Z